NCT00989443View on ClinicalTrials.gov

Safety and Tolerability of Cidofovir Gel Applied on Cervix Squamous Lesions

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

September 30, 2010

Conditions
Uterine Cervical NeoplasmsCervix Intraepithelial Neoplasia
Interventions
DRUG

Cidofovir gel

topical gel applied once a week for 3 weeks

Trial Locations (1)

1070

Erasme Hospital, Brussels

Sponsors
All Listed Sponsors
lead

Mithra Pharmaceuticals

INDUSTRY